NCT06611202 · NOT YET RECRUITING
Enhancing Mobility and Mental Health in Dementia Patients
This trial tests whether a team-based walking and activity program — led by physiotherapists, occupational therapists, and psychologists — can improve mobility, daily functioning, mood, and cognition in people already living with dementia. Clonazepam appears in the intervention list but the summary does not explain its role. Phase NA means this is not a standard drug-efficacy trial; it reads more like a structured care or feasibility study.
You may qualify if
- Clinical diagnosis of dementia.
- Older adults from the age 65 and above
- Must be able to mobilise independently.
- Must be able to engage with minimal tasks that will be based on the
You're excluded if
- Must be free from acute comorbidities: Heart failure; hearing loss;
- Free from significant visual impairment
- Must be free from orthostatic hypotension
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2024-09-24